Gerard Morton - Concepedia

Author

Gerard Morton

Also Known As

G C Morton, G MORTON, G Morton, G. C. Morton, G. Morton, G.C. Morton, GC Morton, GERARD C. MORTON, GERARD MORTON, Gerard C Morton

440

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Sunnybrook Health Science Centre University of Toronto Health Sciences Centre Princess Margaret Cancer Centre Mayo Clinic in Arizona

About

Gerard Morton is an author at Sunnybrook Health Science Centre specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	85	4.7K
2	Health Sciences	25	42	1.9K
3	Engineering	3	3	111
4	Biomedical Engineering	2	2	36
5	Social Sciences	1	1	25

Gerard Morton

125

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer William Morris, Scott Tyldesley, S. Rodda, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation TherapyMedicineAndrogen Suppression CombinedBrachytherapy	2016	714
Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical Progression Richard Choo, Laurence Klotz, Cyril Danjoux, The Journal of Urology	2002	358
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer Jeff M. Michalski, Jennifer Moughan, James A. Purdy, JAMA Oncology	2018	346
American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy Yoshiya Yamada, Leland Rogers, D. Jeffrey Demanes, Brachytherapy Radiation MedicineMedicineHigh-dose-rate Prostate BrachytherapyBrachytherapyOncology	2012	305
Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial Jeff M. Michalski, Yan Yan, Deborah Watkins Bruner, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineProstate Cancer TrialRadiation Therapy Planning	2013	304
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer S. Rodda, Scott Tyldesley, William Morris, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation TherapyLow-dose-rate Brachytherapy BoostMedicineBrachytherapy	2017	303
Target position variability throughout prostate radiotherapy Laura A. Dawson, Katherine Mah, Edmée Franssen, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyMedical ImagingMedicineRadiation Therapy PlanningProstatic Disease	1998	134
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy Gerard Morton, Merrylee McGuffin, Hans T. Chung, Radiotherapy and Oncology UrologyRadiation TherapyMedicineBrachytherapyProstatic Disease	2020	127
PREVALENCE AND PATTERNS OF THE USE OF COMPLEMENTARY THERAPIES AMONG PROSTATE CANCER PATIENTS: AN EPIDEMIOLOGICAL ANALYSIS Robert K. Nam, Neil Fleshner, Eileen Rakovitch, The Journal of Urology	1999	125
Controversies in prostate cancer radiotherapy: consensus development. Himu Lukka, Padraig Warde, Tom Pickles, PubMed Surgical OncologyRadiation MedicineOncologyBrachytherapyRadiation Therapy Planning	2001	115

Page 1